One-Stop Solution for Anti-PTM sdAb Development

Creative Biolabs has been long-term devoted to the development and application of single domain antibody (sdAb). To fill the gaps in the field of PTMs identification and detection, our scientists have built one-stop solutions for anti-PTM sdAb development for our clients all over the world.

Discovery and Development of Novel Anti-PTM sdAb

Post-translational modification (PTM) refers to the covalent and generally enzymatic modification after the protein translation. It usually occurs on the amino acid side chains or at the C- or N- termini of protein with over 30 different classes (e.g. glycosylation, phosphorylation, and methylation). These various PTMs play key roles in a series of cellular processes, such as cell signaling, regulation of gene transcription, and protein degradation. These processes modulate the physical and chemical properties, conformation, folding, stability, and activity of proteins, thereby modifying the functions of proteins and even may lead to cancers. In this case, the identification and detection of PTMs are critical to understand cell biology as well as disease mechanisms and further manipulate the biological mechanisms of protein.

Currently, characterization of PTMs heavily relies on proteomics analyses and anti-PTM antibodies have been served as an essential component for detecting and enriching PTMs. Consequently, the discovery and development of highly specific and potent antibodies to PTMs become very urgent to meet the needs of the market. Single domain antibody has now become a better option than conventional antibody for PTM recognition because of its unique properties of smaller size (~15 kDa) and better penetrability. sdAb is expected to recognize PTM sites more specifically, which can improve the efficiency to identify the target PTM and reduce background caused by cross-reaction. With over ten years of extensive experience, Creative Biolabs can provide customized solutions to generate high specific sdAbs for different PTM sites.

Typical Pathway for PTM-specific sdAb Development

Phase I Target Identification
Phase II Discovery
Phase III Characterization
Phase IV Development
Phase V Manufacture

Features of One-Stop Anti-PTM sdAb Development

Creative Biolabs is a leading service provider that focuses on novel sdAb discovery and development. We are pleased to share our extensive experience and advanced platform to satisfy each of your specific demands. If you are interested in generating high specific anti-PTM sdAbs, please do not hesitate to contact us for more details.

We are offering highly customized CRO services to assist your Single Domain Antibody (sdAb) related projects. Please Contact Us for more details.

Online Inquiry
Interested in our expertise?

Contact us for more information

Get free consultations
USA
  • Tel:
  • Fax:
  • Email:
UK
  • Tel:
  • Email:
Germany
  • Tel:
  • Email:

Enter your email here to subscribe.

Submit

Follow us on

Copyright © 2024 Creative Biolabs. All Rights Reserved.